SEC Form 4 · accession 0001348324-15-000032

LDR HOLDING CORP · LDRH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Mar 2, 2015

Accepted (ET)

Mar 4, 2015 · 8:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348324

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 2, 2015	M	1,304	$4.185	A	3,879	D
Common Stock^F1	Mar 2, 2015	S	1,304	$39.0093	D	2,575	D
Common Stock	Mar 3, 2015	M	189	$4.185	A	2,764	D
Common Stock	Mar 3, 2015	M	2,673	$4.185	A	5,437	D
Common Stock	Mar 3, 2015	M	923	$15.00	A	6,360	D
Common Stock^F2	Mar 3, 2015	S	3,785	$38.0246	D	2,575	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Incentive Stock Option (right to buy)^F3	$4.185	Mar 2, 2015	M	1,304	D	Apr 23, 2013	May 21, 2022	Common Stock	1,304	7,161	D
Incentive Stock Option (right to buy)^F3	$4.185	Mar 3, 2015	M	189	D	Apr 23, 2013	May 21, 2022	Common Stock	189	6,972	D
Incentive Stock Option (right to buy)^F4	$15.00	Mar 3, 2015	M	923	D	Oct 11, 2013	Oct 8, 2023	Common Stock	923	19,631	D
Non-Qualified Stock Option (right to buy)^F3	$4.185	Mar 3, 2015	M	2,673	D	Apr 23, 2013	May 21, 2022	Common Stock	2,673	12,479	D

F1The price indicated is the weighted average sale price for the shares sold. The individual sale prices for the shares indicated range from $39.00 to $39.02. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold.
F2The price indicated is the weighted average sale price for the shares sold. The individual sale prices for the shares indicated range from $38.00 to $38.16. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold.
F3ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of April 23, 2012, then in thirty-six equal monthly installments thereafter.
F4ISO becomes exercisable in combination with NQSO granted on the same date wherein the shares vest in forty-eight equal monthly installments from the vesting commencement date of September 11, 2013.